Kiniksa Pharmaceuticals CFO Mark Buys Shares, Sells Shares on December 8, 2025.

Kiniksa Pharmaceuticals International, plc [KNSA] has recently disclosed that Ragosa Mark, the company's Chief Financial Officer, has made several transactions involving the purchase and sale of shares. On December 8, 2025, Mr. Mark acquired a total of 42,941 shares at an average price of $11.97 per share. Specifically, he purchased 16,164 shares at $11.1 per share, 16,165 shares at $11.97 per share, and 10,512 shares at $10.76 per share. Additionally, on the same day, he sold 42,841 shares at $41.49 per share. These transactions were reported in accordance with regulatory requirements.